-
Rail journey offers a slower route to a Berlin city break
-
Energy bill plan could use HMRC income data to target support
-
Arsenal control title race as Manchester United fall into bottom three
-
Business owner earning £6,000 a month tackles £70,000 debt
-
Suspected Krakow gunman dies after attack that killed six
-
Nvidia chief faces inquiry after disclosing affair with suspected Chinese agent
-
Carrick backs Dalot after hostile reception from Manchester United fans
-
Comet returns as online electrical marketplace 14 years after collapse
-
Aston Villa Defy History With Rare Victory at Old Trafford
-
Brussels Education Unions Schedule Major November Protest Over Funding and Reforms
-
Crowds Gather at San Francisco Park for Elizabeth Holmes Lookalike Tournament
-
Hancock Health Expands Robot Specimen Delivery to Parkway Building, Adding Scheduled and On-Demand Runs to the Lab
-
Releaf Unveils UK-first THCV for Weight Management
-
Gabriel Provides Corporate Update
-
AsiaFIN's Insite MY Holdings and MENA Insite MY Sign Distributorship Agreement and Announce Second Bank Customer in Saudi Arabia
-
Ai4 Celebrates Successful Debut of Applied AI Research Conference (AAIRC), Bridging Academic Research and Industry Innovation
-
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
-
Nextech3D.ai Closes $720,000 Management-Led Private Placement
-
CoTec Holdings Corp. Notes HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
-
Silver Storm Reports Concentrate Deliveries from La Parrilla
-
Ispire Technology Inc. Reports First Quarter Fiscal Year 2027 Financial Results
-
HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
-
Hillcrest and Equipmake Sign Definitive Agreement to Jointly Develop and License ZVS Inverter Technology for Heavy-Duty Electric Vehicles
-
Tintina Mines Intersects 460m at 0.50% CuEq at the Dos Amigos Copper-Gold Project in Chile
-
Pace Launches Three-Business-Day Culture-Based 'L. pneumophila' Testing
-
Opti Digital Launches NEXA, an AI-Powered Intelligence Layer
-
DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 09
-
Making Your Home Safer for Aging Parents: Accessibility Renovations That Add Value
-
New 401k Gold IRA Investment Guide Explains the Best Way to Invest in Gold for Retirement (2026 Update)
-
United States Antimony Corporation Announces Webcast Time set for Thursday, November 12, 2026 at 4:15 PM ET to Report on Third Quarter and Nine Months Ended September 30, 2026 Financial and Operating Results
-
Pacific Edge Labs Publishes More Than 120 Independent Lab Reports, Each Listed With the Testing Lab's Own ID
-
Regentis Signs Exclusive Distribution Agreement with AMI Technologies to Commercialize GelrinC(R) in Israel
-
Modular Medical Completes Comprehensive Patient Market Research Study with Thrivable, Reinforcing Strong Interest in Simplified Insulin Delivery
-
Shelfietech Launched New Retail Software Platform
-
A Holiday-Season Moment for Penny-Stock Followers and Microcap Visionaries as Elektros Moves Its EV Patent Forward
-
Dolphin Subsidiary 42West Drives Global Communications Behind Box Office Leaders Godzilla Minus Zero and Ramayana
-
Visterra Landscape Group Expands Into Arkansas With Strategic Investment In Little Rock Landscape
-
Santa Claus Has Come Early: Elektros Brings An Early-Christmas Spark To Its Patented EV Charging Vision
-
SMX Is Building a Verifiable Identity Layer for Fashion, From Cotton Fields to Luxury Resale
-
Gladstone Land Corporation Earnings Call and Webcast Information
-
The Metals Royalty Company to Host Corporate Update Webinar on November 16, 2026
-
Aptevo Presents Preclinical Data at SITC 2026 Showing Potential to Overcome Immune Suppression in Solid Tumors
-
Eylsia Nicolas Launches Global "Wake Me Up" Franchise After Surpassing 100 Million Meta Views in One Week
-
BioLargo Targets Growing Industrial PFAS Market with MasterClass at International Water Conference
-
Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference
-
IGC Pharma Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
-
iPS Cell Research Accelerates Drug Discovery for ALS and Spinal Cord Injury
-
Central Tokyo Apartment Rents Forecast to Rise 11% by 2030
Featured
Last news
VSee Health Secures Three-Year Platform Services Agreement with the Region's Sole Level 1 Trauma Center and Academic Health System
Volume-based contract with no revenue ceiling covers virtual urgent care and behavioral health across more than 100 facilities; services commence January 1, 2026.
Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis and Treatment of Autism Spectrum Disorder
Biomarker discovery opens the way for development of novel transformational technology in Autism Spectrum Disorder.
Jerash Holdings to Report Financial Results for Fiscal 2026 Second Quarter on Wednesday, November 12, 2025
FAIRFIELD, NJ / ACCESS Newswire / November 4, 2025 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made sportswear and outerwear for leading global brands, today announced it will release its financial results for its fiscal 2026 second quarter ended September 30, 2025, before the market opens on Wednesday, November 12, 2025. The Company will host an investor conference call the same day.
Reservoir Media Announces Second Quarter Fiscal 2026 Results
Double-Digit Growth in Recorded Music Driven by Digital and Synch DemandOutlook for Revenue and Adj. EBITDA Raised for Fiscal 2026
Specificity Readies for Next Phase of Growth with Effective S-1 Registration Statement Enabling Access to Expansion Capital
Successfully Completes the Company's Process of Regaining Full SEC Compliance
Mosaic Announces Completion of Sale of Potash Mining Operations in Brazil to VL Mineracao
TAMPA, FL / ACCESS Newswire / November 4, 2025 / The Mosaic Company (NYSE:MOS) announced today the completion of the previously announced transaction with VL Mineração Ltda. ("VL Mineração") for the sale of Mosaic Potássio Mineração Ltda., the entity that operates the Taquari-Vassouras potash mine located in Rosário do Catete, Sergipe, Brazil. VL Mineração will take over the mining and processing of potash, as well as maintenance and other obligations. In exchange, Mosaic will receive $27 million (USD) in cash, with $12 million paid at closing, $10 million one year after closing, and up to $5 million over six years as contingent payments. VL Mineração will assume responsibility for approximately $22 million in asset retirement obligations (ARO).
Coalition for Patient Rights Announces Update on Their Inaugural Hoedown Nov. 15; Lead-Up Performance by Country Artist Jonny Hazard at Downtown Container Park Nov. 5
Toy drive with Operation Warm Heart benefits Airmen at Nellis & Creech AFBs; Family fun, food, spirits and beverages made affordable and accessible by the Compassion Center; Sponsors urged to confirm placements as inventory nears capacity
BioNxt Reports "Intention to Grant" Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies
VANCOUVER, BC / ACCESS Newswire / November 4, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, Vektor Pharma TF GmbH, has received an "Intention to Grant" notification from the European Patent Office (EPO) for European patent application no. 23 729 446.7, covering a sublingual, orally dispersible thin-film formulation of cladribine for the treatment of multiple sclerosis (MS) and related neurodegenerative diseases.
Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding
Independent Expert Consensus Confirms Clinical Relevance of CTCs and Identifies Parsortix Platform as Leading Next-Generation TechnologyExpert consensus predicts integration of CTC testing into routine clinical practice within 5 yearsCTCs provide distinct and impactful information that is not captured by circulating tumour DNA (ctDNA)40% of the expert panel identified the Parsortix® platform as the most promising next generation technology for clinical applications
Starbucks cedes China control to Boyu Capital
Starbucks announced Monday it will sell a controlling stake in its Chinese retail operations to investment firm Boyu Capital in a deal valuing the business at around $4 billion.
Worker rescued after medieval tower partly collapses in Rome
Rescuers on Monday saved a worker who became trapped when the medieval tower he was helping renovate in Rome partly collapsed, city authorities said.
Trial opens in 1st US civil case on 2019 Boeing MAX crash
Relatives of victims in the fatal crash of a Boeing 737 MAX plane operated by Ethiopian Airlines headed to court Monday for the first civil trial relating to the 2019 calamity.
Medieval tower partially collapses in Rome, trapping worker
A medieval tower in central Rome that was under renovation partially collapsed on Monday, with one worker trapped alive under rubble, authorities said.
Shein bans sex dolls after France outrage over 'childlike' ones
Asian e-commerce giant Shein said Monday it was banning all sex dolls from sale on its sites after French authorities condemned it for featuring ones resembling children.
Ex-France international Ben Yedder to stand trial on rape charges
Former French international Wissam Ben Yedder will stand trial for alleged rape, attempted rape, and sexual assault, the prosecutor's office in Nice told AFP on Monday.
Christian, Muslim Nigerians push back on threatened US strikes
Nigerians across the religious spectrum pushed back Monday on US President Donald Trump's threats of military intervention over the killing of Christians in the country.
'Heroic' worker praised as man charged over UK train stabbings
A man has been charged with 10 counts of attempted murder following a mass stabbing on a London-bound train, as a critically wounded train worker was hailed Monday as a hero for stepping in to protect passengers.
Spain regional leader resigns, a year after deadly floods
The heavily criticised leader of Spain's Valencia region said on Monday he was stepping down, a year after the area was hit by floods that were the country's deadliest natural disaster in a generation.
Video game creators fear AI could grab the controller
Generative artificial intelligence models capable of dreaming up ultra-realistic characters and virtual universes could make for cheaper, better video games in future, but the emerging technology has artists and developers on edge.
Afghan govt says quake kills 20, injures over 500
A strong earthquake killed at least 20 people in northern Afghanistan, authorities said Monday, just months after another deadly tremor that left the country reeling.
Afghanistan quake kills 20, injures over 300: health ministry
A strong earthquake killed at least 20 people in northern Afghanistan, authorities said Monday, just months after another deadly tremor that left the country reeling.
Trump's global tariffs to face challenge before Supreme Court
The US Supreme Court is set to hear arguments Wednesday on the legality of Donald Trump's unprecedented use of powers for sweeping global tariffs in a case striking at the heart of the president's economic agenda.
Daughter of 'underground' pastor urges China for his release
When Grace Jin Drexel lost contact with her father in China weeks ago, her worries swiftly turned into fear -- he, alongside more than 20 others, had been detained in a national crackdown on his underground church.
Dr. Kurt A Dasse Exploring Love, Law, and Resilience - Ingram Publisher's House
Dr. Kurt A. Dasse Unveils His Gripping Works of Fiction Exploring Love, Law, and Resilience
Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting
NEWARK, CALIFORNIA / ACCESS Newswire / November 3, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical data on rusfertide in polycythemia vera, including the Phase 3 VERIFY study, will be the focus of four presentations at the 67th Annual American Society of Hematology (ASH) Annual Meeting being held in Orlando, Florida, from December 6-9, 2025.
International Pool Spa Patio Expo 2025 Sets New Industry Benchmarks with Global Participation from 40 Countries
Pool and spa professionals drive critical conversations in retail performance, safety innovation and next-generation equipment technologies.
Deck Expo Delivers Content, Product Exploration and Enhanced Technology Ahead of Next Year's Outdoor Living Season
LAS VEGAS, NV / ACCESS Newswire / November 3, 2025 / Deck Expo, North America's largest gathering place for deck and outdoor living professionals, concluded on October 24, uniting a global audience to explore cutting-edge innovations, share industry insights and create strategic partnerships that will shape the future of outdoor living design and construction.
Vanderbilt Report: Brookmount Explorations, Inc to Spin Off Gold Assets, BMXI Shareholders Receive Stake in New Company
BRISTOL, TN / ACCESS Newswire / November 3, 2025 / Brookmount Explorations Inc. (OTCID:BMXI) is executing a corporate restructuring that puts shares of a new gold-focused company directly into current shareholders' hands. The move creates North America Gold, Inc., a separate entity that will own three gold properties currently held by Brookmount.
Medical Care Technologies, Inc (OTC PINK:MDCE) Announces Development of AI-Powered Wellness App Suite with Global Reach
Bringing Next-Generation Wellness to a Global Audience with Multilingual, Accessible AI Solutions
Pebble Beach's Iconic Lodge Reopens Following Extensive Transformation
Reimagined Stillwater restaurant debuts new design, menu and coastal dining experienceDownload more Lodge renovation photos here.
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting
- CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody- Phase 1 dose escalation study in Immune Thrombocytopenia (ITP) results and update
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules
Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech / pharma companiesAddressing large and growing market